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Background: Comorbid personality disorders may predispose patients with mood disorders to suicide
attempts (SAs), but factors mediating this effect are not well known.
Methods: Altogether 597 patients from three prospective cohort studies (Vantaa Depression Study, Jorvi
Bipolar Study, and Vantaa Primary Care Depression Study) were interviewed at baseline, at 18 months,
and in VDS and PC-VDS at 5 years. Personality disorders (PDs) at baseline, number of previous SAs, life-
charted time spent in major depressive episodes (MDEs), and precise timing of SAs during follow-up
were determined and investigated.
Results: Overall, 219 (36.7%) patients had a total of 718 lifetime SAs; 88 (14.7%) patients had 242 SAs
during the prospective follow-up. Having any PD diagnosis increased the SA rate, both lifetime and
prospectively evaluated, by 90% and 102%, respectively. All PD clusters increased the rate of new SAs,
although cluster C PDs more than the others. After adjusting for time spent in MDEs, only cluster C
further increased the SA rate (by 52%). Mediation analyses of PD effects on prospectively ascertained SAs
indicated significant mediated effects through time at risk in MDEs, but also some direct effects.
Limitations: Findings generalizable only to patients with mood disorders.
Conclusions: Among mood disorder patients, comorbid PDs increase the risk of SAs to approximately
two-fold. The excess risk is mostly due to patients with comorbid PDs spending more time in depressive
episodes than those without. Consequently, risk appears highest for PDs that most predispose to
chronicity and recurrences. However, also direct risk-modifying effects of PDs exist.
& 2015 Elsevier B.V. All rights reserved.1. Introduction
Mood and personality disorders carry a significant risk of sui-
cide. Between one-half and two-thirds of all suicides occur in
patients with mood disorders (Cavanagh et al., 2003), with lifetime
risk of suicide in mood disorders in the 5–6% range, the risk being
somewhat higher in bipolar disorder (BD) than in major depres-
sive disorder (MDD) (Nordentoft et al., 2011). Moreover, comorbid
psychiatric disorders increase suicide risk (Nordentoft et al., 2011).
Of individuals who die by suicide, 30–40% of have at least onery, University of Helsinki, P.O.
sä).personality disorder (PD) (Foster et al., 1997; Henriksson et al.,
1993) and nearly all of them have also comorbid depressive or
substance use disorders, or both (Cheng et al., 1997; Henriksson
et al., 1993). Thus, individuals with co-occurring mood and per-
sonality disorders comprise the vast majority of all suicides (Foster
et al., 1997). Knowing the risk factors for suicide is necessary for
rational preventive decisions. However, given suicide’s low base
rate, much risk factor research has focused on suicide attempts
(SAs) as a proxy for suicide. The risk factors for SAs and suicide are
mainly similar, although completers are more often males, have
more psychotic symptoms, and use more lethal methods (Hawton
et al., 2013; Isometsa, 2014).
Risk factors for SAs in mood disorder patients include previous
SAs, younger age, hopelessness, impulsive-aggressive traits, poor
perceived social support, and concurrent anxiety, substance use,
Table 1
Methods used in the Jorvi Bipolar Study (JoBS), the Vantaa Depression Study (VDS), and the Vantaa Primary Care Depression Study (PC-VDS).
Cohort JoBS VDS PC-VDS
Timing of screening Jan 1, 2002 to Feb 28, 2003 Feb 1, 1997 to May 31, 1998 Jan 1, 2002 to Dec 31, 2002
Catchment area Adjacent cities of Espoo, Kauniainen,
and Kirkkonummi (population 261 100
in 2002)
City of Vantaa (population 169 000 in 1997) Two districts in the city of Vantaa (popu-
lation of 63,400 in 2002)
Setting Department of Psychiatry, Jorvi Hospi-
tal, Helsinki University Central Hospital,
Espoo, Finland
Department of Psychiatry of the Peijas Medical
Care District, Helsinki University Central Hospital,
Vantaa, Finland
Primary Health Care Organization of the
City of Vantaa, Finland
Three health centers
Two maternity clinics served by 30 gen-
eral practitioners with population-based
responsibility
Target group All psychiatric patients aged 18-59
years
All psychiatric patients aged 20-59 years Consecutive primary care patients aged
20-59 years in general practitioners’
waiting room(1) seeking treatment
(2) referred to treatment, or
(3) already in treatment with an acute
deteriorating clinical state
(1) seeking treatment
(2) referred to treatment, or
(3) already in treatment with an acute dete-
riorating clinical state
Exclusion from screening ICD-10 schizophrenia ICD-10 schizophrenia, BD I Poor general health status prohibiting
completion of screening form
Screening procedure (1) Mood Disorders Questionnaire, 7/
13 items positive, or
(2) Clinical suspicion of BD (N¼28)
(1) Five screening questions for depression from
SCAN, 1 positive, or
(2) Scale for Suicide Ideation, score Z 6
(1) PRIME-MD: positive answer to either
question concerning depressed mood
or anhedonia during the past month,
and
(2) Telephone interview: one or more
main symptoms of depression accord-
ing to SCID-I/P
Total screened 1630 806 1111(8 refused)
Screened positive 546 703 402
Refusals Screening 46 (2.8% of all screened), In-
terview 49 (9.0% of positive screens)
161 (22.9%) 37 (9.2%)
Diagnostic interview After informed consent, DSM-IV (SCID-
I/P and SCID-II)
After informed consent, DSM-IV (Axis I, SCAN)
and DSM-III-R (SCID-II, modified to DSM-IV)
After informed consent DSM-IV (SCID-I/P
and SCID-II)
Inclusion criteria DSM-IV type I or II with a new de-
pressive, manic, hypomanic, mixed, or
depressive mixed episode of BD
DSM-IV MDD with a new depressive episode DSM-IV unipolar depressive disorders
with no current treatment in psychiatric
care
Cohort 191 MDD patient with a current epi-
sode at baseline (65 inpatients and 126
outpatients)
269 BD patient with a current phase at baseline
(46 inpatients, 223 outpatients)
137 outpatients from primary care; 91
MDD patients with current episode and




Anxiety Disorder 44.5% Anxiety Disorder 57% Anxiety Disorder 43%
Substance Use Disorder 19.9% Alcohol Use Disorder 25% Substance Use Disorder 12%
Eating Disorder 7.9% Bulimia Nervosa 2% Somatoform Disorder 12 %
Somatoform Disorder 5..2% Personality Disorder 44% Eating Disorder 2%
Personality Disorder 42.9% 1. Cluster A 19.0%
2. Cluster B 14.5%
3. Cluster C 31.6%
Personality Disorder 52%
1. Cluster A 9.9%
2. Cluster B 24.6%
3. Cluster C 23.0%
1. Cluster A 1.0%
2. Cluster B 28.0%
3. Cluster C 32.0%
Number of patients at
6-month follow-up
176 (92.1%) 229 (85.1%) –
18-month follow-up Number
of patients
161 (84.3%) 198 (77.3%) 92 (88.5%)
Participants vs. non-
participants
Somewhat older (mean 39.0 years, SD
11.9 vs. 33.7 years, SD 12.1, t¼2.711,
df¼189, p¼0.007)
Mean time for interview 19.873.0 months
5-year follow-up Number of
Patients
– 182 (67.7%) 112 (82.0%)
Switch of diagnosis 29 BD, 1 schizophrenia, 2 schizoaffective disorder 5 BD
More often female (72.1% vs. 55.6%, χ2¼6.581,
p¼0.010), married or cohabiting (75.6% vs. 59.7%,
χ2¼7.725, p¼0.005), less alcohol dependence at
baseline (39.5% vs. 72.3%, χ2¼16.064, po0.001)
No difference in age, gender, or baseline
depression severityParticipants vs. non-
participants
Mean time for interview 5.2 years 5.2 years
Number of patients with fol-





20 videotaped diagnostic interviews;
kappa coefficient for BD¼1.0; not tes-
ted for comorbidity
20 videotaped diagnostic interviews; kappa
coefficient for current MDD¼ 0.86 (95% CI¼
0.58–1.00); not tested for comorbidity
20 videotaped diagnostic interviews;
kappa coefficient for current MDD and
current subsyndromal diagnoses ¼ 1.0;
not tested for comorbidity
Assessment of suicide attempt By interview and medical and psychia-
tric records at baseline and at 6- and
18-months
By interview and medical and psychiatric records
at baseline and at 6- and 18-months and at
5-years
By interview and medical and psychiatric
records at baseline and at 18-months and
at 5-years
Symptom assessment YMRS, HAM-D, BDI, BAI (baseline and
18 months). Psychotic symptoms as
part of semistructured interview.
HAM-D, BDI, BAI (baseline, 18 months, and
5 years). Psychotic symptoms as part of semi-
structured interview
HAM-D, BDI, BAI (baseline, 18 months, and
5 years). Psychotic symptoms as part of
semistructured interview
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Table 1 (continued )
Cohort JoBS VDS PC-VDS
Internal consistencies of scales (Cronbach´s alphas) for the scales used were good in patient cohorts in all time-points [TCI-R (0. BDI (0.86–0.95), BAI (0.89–0.93), HAM-
D (0.70–0.88), and YMRS (JoBS: 0.59–0.88)].
BAI¼ Beck Anxiety Inventory; BD¼ Bipolar Disorder; BDI¼ Beck Depression Inventory; HAM-D¼ Hamilton Depression Rating Scale; MDD¼ Major Depressive Disorder;
PRIME-MD¼ Primary Care Evaluation of Mental Disorders; SCID-I/P¼ Structured Clinical Interview for DSM-IV Axis I Disorders, research version, patient edition with
psychotic screen; SCID-II¼ Structured Clinical Interview for DSM-IV Personality Disorders; WHO SCAN¼ World Health Organization Schedules for Clinical Assessment in
Neuropsychiatry, version 2.0; YMRS¼ Young Mania Rating Scale
P. Jylhä et al. / Journal of Affective Disorders 190 (2016) 632–639634and PD (for reviews, see (Beghi et al., 2013; Hawton et al., 2013;
Isometsa, 2014)). Multiple interacting risk (e.g. above mentioned)
and protective (e.g. meaningful and important relationships) fac-
tors influence suicidal behavior (Mann et al., 1999). However, in
prospective studies (Holma et al., 2010, 2014; Riihimaki et al.,
2014a; Valtonen et al., 2008) we have shown that a major de-
terminant, with a consistently high population-attributable frac-
tion, is the time spent in high-risk illness phases. Compared with
euthymia, the incidence of SAs during major depressive phases is
25-fold and during mixed illness episodes in BD 65-fold (Holma
et al., 2014). Among patients with mood disorders, suicidal acts in
the absence of an illness episode are rare (Holma et al., 2010, 2014;
Riihimaki et al., 2014a; Valtonen et al., 2008). Both comorbid DSM-
IV cluster B (Skodol et al., 2011) and C (Oleski et al., 2012) PDs have
been shown to increase time that an individual spends in major
depressive episodes (MDEs).
The relationship between mood disorder and comorbid PDs
and SAs has been investigated in longitudinal epidemiological
(Bolton et al., 2010; Oleski et al., 2012) and clinical (Galfalvy et al.,
2006; Oquendo et al., 2007; Stringer et al., 2013; Undurraga et al.,
2012) studies among mood disorder patients and in longitudinal
clinical studies among PD patients (Soloff and Chiappetta, 2012;
Yen et al., 2003). In these studies, cluster B PDs, especially bor-
derline PD, have been established as a risk factor for SAs, whereas
cluster A and C PDs have received less attention. The most con-
sistent predictors for a future SA have been borderline PD co-
morbid with MDD (Bolton et al., 2010; Soloff and Chiappetta, 2012;
Soloff and Fabio, 2008; Yen et al., 2003), BD with current MDE
(Galfalvy et al., 2006) , and both MDD and BD with current MDE
(Oquendo et al., 2007) or dysthymia (Stringer et al., 2013). Also
baseline cluster C (Oleski et al., 2012), dependent (Bolton et al.,
2010), avoidant (Bolton et al., 2010), paranoid (Bolton et al., 2010),
schizoid (Bolton et al., 2010), schizotypal (Bolton et al., 2010), or
any (Bolton et al., 2010; Undurraga et al., 2012) PD comorbid with
MDD or MDE in BD patients has been associated with higher rates
of SAs at follow-up. A number of other risk factors e.g. socio-
demographic factors, number of depressive symptoms, other co-
morbid disorder, previous suicidal behavior have been controlled
in the aforementioned studies, but not the proportion of time
spent in MDEs during the follow-up; yet, it is a key predictor of
accumulated risk for suicidal acts (Holma et al., 2010, 2014; Rii-
himaki et al., 2014a; Valtonen et al., 2008).
In this prospective cohort study of mood disorder patients, we
aimed to investigate the relationship between comorbid PDs and
future SAs. We hypothesized that 1) baseline comorbid cluster C
and borderline PDs would increase the rate of SAs indirectly by
increasing time spent in MDEs. Moreover, 2) we expected that
borderline PD would also (directly) modify the risk of SAs during
MDEs.
Therefore, we investigated the relationship between comorbid
PD and 1) lifetime (total retrospective and prospective) SAs and 2)
prospectively evaluated new SAs during the follow-up. We also
tested 3) whether comorbid PD acts directly on the rate of SAs or
indirectly by increasing the duration of MDEs during the follow-
up. In analyses of prospectively evaluated SAs, we 4) controlled forconfounding sociodemographic and clinical risk factors. Finally, we
conducted formal mediation analyses.2. Methods
Patients came from three separate but comparable cohorts
(Jorvi Bipolar Study, JoBS; Vantaa Depression Study, VDS; Vantaa
Primary Care Depression Study, PC-VDS), collaborative research
projects of the Mood Disorder Research Unit of the Department of
Mental Health and Substance Use of the National Institute of
Health and Welfare, Helsinki, Finland (Principal Investigator EI).
The pertinent ethics committee approved the research protocols.
The detailed methodologies have been described elsewhere for
JoBS (Mantere et al., 2004, 2008), VDS (Holma et al., 2008; Mel-
artin et al., 2002), and PC-VDS (Riihimaki et al., 2014b; Vuorilehto
et al., 2005) (see also Table 1).
2.1. Screening and baseline evaluation
Altogether 3555 primary care or psychiatric patients were
screened for acute phase of unipolar depressive disorder (PC-VDS)
or BD (JoBS) or MDD (VDS). Patients were fully informed about the
study and gave written informed consent. Diagnoses were based
on semistructured interviews (Table 1). Most of the interviewers
were psychiatrists or doctors specializing in psychiatry and two
experienced clinical psychologists. In PC-VDS, two-thirds of the
patients had MDD, and the rest had dysthymia, currently sub-
syndromal but lifetime MDD, or true minor depression. The final
baseline cohorts included 191 DSM-IV BD I and II patients (JoBS),
269 MDD patients (VDS), and 137 unipolar depressive disorder
patients (PC-VDS). Interrater agreement in diagnostic interviews
was excellent (kappa 0.86–1.00) (Mantere et al., 2008; Melartin
et al., 2002; Riihimaki et al., 2014b).
Full DSM-IV axis I diagnoses (Structured Clinical Interview for
DSM-IV Disorders, SCID-I/P (First et al., 2002) in JoBS and PC-VDS;
Schedules for Clinical Assessment of Neuropsychiatry, SCAN (Wing
et al., 1990) in VDS) and axis II diagnoses (Structured Clinical In-
terview for DSM-IV Personality Disorders, SCID-II for DSM-IV (First
et al., 1997) in JoBS and PC-VDS; SCID-II for DSM-III-R in VDS) were
made. Prevalence of comorbid psychiatric diagnoses are men-
tioned in Table 1. Information was also gathered on demographic
characteristics, current symptomatology using the 17-item Ha-
milton Depression Scale, HAM-D (Hamilton, 1960), the 21-item
Beck Depression Scale, BDI (Beck et al., 1961), the 21-item Beck
Anxiety Scale, BAI (Beck et al., 1988), and the Young Mania Rating
Scale, YMRS (Young et al., 1978), and illness history using a ret-
rospective life-chart.
2.2. Follow-up
After baseline assessments, patients were interviewed at 6
(JoBS and VDS) and 18 (JoBS, VDS, and PC-VDS) months and at
5 years (VDS and PC-VDS). Repeated SCID-I/P (JoBS and PC-VDS at
all follow-ups, and VDS at 5 years), SCAN 2.0 (VDS at 18 months),
Table 2
Baseline sociodemographic and clinical characteristics and mean scores and stan-
dard deviations (SD) of Beck Depression Inventory (BDI), Beck Anxiety Disorder
(BAI), Hamilton Rating Scale for Depression (HAM-D), and Perceived Social Support








n % n % χ2 p
Gender ns
Female 155 70.8 247 65.3




70 32.2 150 37.7
Vocational 52 24.0 93 25.1
None 95 43.8 138 37.2
Marital statusb 4.354 0.037
Married or
cohabiting
94 43.1 194 52.0
Single 124 56.9 179 48.0
Work statusc ns
Employed 147 68.1 259 69.4




Any anxiety disorder 125 57.1 171 45.2 7.775 0.005
Alcohol dependence,
current
33 15.1 38 10.1 ns
Any personality dis-
order, current
121 55.3 150d 39.7 13.559 o0.001
Cluster A 32 14.6 45d 11.9 ns
Paranoid 27 12.3 44d 11.7 ns
Schizoid 5 2.3 1d 0.3 5.660 0.017
Schizotypal 2 0.9 0d 0 ns
Cluster B 67 30.6 65d 17.2 14.323 o0.001
Histrionic 3 1.4 6d 1.6 ns
Narcissistic 4 1.8 10d 2.7 ns
Borderline 63 28.8 54d 14.3 18.317 o0.001
Antisocial 8 3.7 6d 1.6 2.566 ns
Cluster C 78 35.6 95d 25.2 7.297 0.007
Avoidant 57 26.0 56d 14.9 11.256 0.001
Dependent 15 6.8 14d 3.7 ns
Obsessive–
Compulsive
24 11.0 32 8.5 ns
Psychotic features,
lifetime
82 37.4 62 16.4 33.541 o0.001
Mean SD Mean SD t p
Age 38.8 12.2 41.2 12.4 2.241 0.025
BDI 27.1 11.1 22.6 10.0 5.166 o0.001
BAI 24.2 12.5 19.4 11.3 4.782 o0.001
HAM-D 16.0 7.3 13.1 5.9 5.305 o0.001
PSSS-Re 42.0 12.6 43.2 12.6 ns
a missing data 2/219, 7/378,
b missing data 1/219, 5/378,
c missing data 3/219, 5/37,
d missing data 1/378
P. Jylhä et al. / Journal of Affective Disorders 190 (2016) 632–639 635and SCID-II interviews and all observer- and self-reported symp-
tom scales were included at all follow-up assessments. Course of
illness was documented on a prospective life-chart based on DSM-
IV criteria (Holma et al., 2008; Mantere et al., 2008; Riihimaki
et al., 2014b; Vuorilehto et al., 2009). Criteria for hypomania were
as in the DSM-IV, except duration of at least 2 days. Socio-
demographic characteristics are presented in Table 2.
2.3. Suicide attempts
A suicide attempt was defined as a self-injurious behavior with
non-fatal outcome accompanied by evidence that the person had
at least some degree of intent to die (APA, 2003; Holma et al.,
2010, 2014; Riihimaki et al., 2014a; Valtonen et al., 2008). Atbaseline, information about previous SAs was obtained by inter-
views and psychiatric records. Information regarding SAs during
follow-up was based on both patient interview and psychiatric and
general medical records. During follow-up we assessed episodes of
depression and SAs independently by questioning the patients
first about their life events and mood, and then about SAs, to avoid
automatically attributing the disorders to each other or the acts to
the episode.
2.4. Study design
We examined whether baseline comorbid PDs predicted
number of prospectively ascertained SAs at follow-up or were
associated with number of lifetime (including prospective) at-
tempts. Formal mediation tests were conducted for all three PD
clusters and for specific PDs on SA risk. For further methodological
details, see Supplementary materials.
2.5. Statistical methods
The statistical data analyses were conducted using R-software,
64-bit Linux version 2.15.3. Poisson regression was applied in
modeling the number of SAs per month (participant-specific ‘off-
set’ for the time of exposure) as a function of independent vari-
ables (see online supplementary materials for further details).
Overdispersal was present when studying lifetime attempts (dis-
persion test in “AER” R-package version 1.2–1), and thus, quasi-
Poisson models were used for this outcome (Cameron and Trivedi,
1990). Missing data were modeled using Multiple Imputation by
Chained Equations (see online supplement), and imputed results
are presented along with a non-imputed sensitivity analysis (van
Buuren and Groothuis-Oudshoorn, 2011). As a further sensitivity
analysis, we studied whether PDs were differentially associated
with having attempted suicide (status) versus the number of at-
tempts. The status outcome of having attempted suicide or not
was modeled using Logistic Regression models. The possible
mediating role of depressive episodes between PD and SA was
studied using “mediation” R-package (version 4.4.3), with a linear
regression model for time spent in MDEs, a Poisson regression
model for number of SAs, and a logistic regression for attempter-
status outcome (Imai et al., 2010). For a statistical power analysis,
see the online supplement.3. Results
In total, 219 (36.7%) patients had had one or more lifetime
(total retrospective and prospective) SAs, whereas 88 (14.7%) pa-
tients made one or more attempts during their life-charted follow-
up period. Total number of lifetime SAs in the whole sample was
718 (mean¼1.20; s.d.¼2.79). Altogether 242 new attempts were
observed during the follow-up period, with the average rate of
new attempts being 0.018 attempts/month (s.d.¼0.074).
3.1. Personality disorders in relation to suicide attempt rates
Participants with any PD diagnosis at baseline had a 90% in-
crease in the rate of lifetime SAs, and a 102% increase in pro-
spectively observed SAs relative to participants without PDs. Even
during the high-risk state of MDE, presence of any PD increased
the rate of a new SA by 39% and a cluster C disorder nearly dou-
bled (90% increase) the SA rate. See Table 3 for results for all PD
clusters, for borderline PD specifically, and, as a reference, also for
previous attempt.
A post-hoc analysis of the cluster C diagnoses revealed that
avoidant PD (81.5% increased rate of SAs [95% CI¼22.0%, 168.0%])
Table 3
Personality disorder-associated increases in suicide attempt (SA) rates.
Lifetime SAsa New SAsb
Variable Increase (%) low CI high CI n Increase (%) low CI high CI n
Any PD 90.4 30.3 181.2 596 101.6 53.7 166.4 554
Cluster A 35.7 21.8 122.4 596 68.3 21.5 128.8 554
Cluster B 99.4 35.4 191.0 596 67.4 25.7 121.7 554
Cluster C 88.1 29.6 171.0 596 122.2 71.6 188.1 554
Borderline PD 120.6 49.2 222.7 596 79.5 33.9 138.9 554
Previous attempt – – – 227.0 150.3 327.7 555
New attempts during MDEc New attempts, multiple imputationd
Increase (%) low CI high CI n Increase (%) low CI high CI n
Any PD 38.9 6.9 110.9 451 101.5 53.1 165.2 555
Cluster A 26.3 19.3 92.6 451 68.3 22.7 130.8 555
Cluster B 31.8 11.7 95.2 451 67.3 26.0 122.2 555
Cluster C 89.9 29.9 179.3 451 122.1 71.5 187.8 555
Borderline PD 33.3 11.0 97.7 451 79.3 34.3 139.5 555
Previous attempt 130.6 53.1 246.8 452 227.0 148.5 330.4 555
PD¼personality disorder; CI¼95% confidence interval; n¼sample size; MDE¼major depressive disorder.
a Estimates for lifetime suicide attempt rates are from the quasi-Poisson regression model, adjusted for age, sex, and sampling cohort by additional indicator covariates.
Missing PD data 1/597.
b Estimates for new suicide attempt rates are from the Poisson regression model, adjusted for age, sex, sampling cohort, an indicator for having attempted suicide
previously, and number of previous attempts. Altogether 555 participants were followed with a life-chart methodology, but some outcomes had missing values, leading to
smaller analytic sample sizes.
c The analysis for new SAs was repeated for new attempts during MDE, using time spent in MDE as the exposure instead of total follow-up time. Patients without MDEs
were excluded.
d The analysis for new SAs was repeated using multiple imputation of missing variables for those participants that had a life-charted period of exposure.
Fig. 1. Mediation analyses. Results from mediation analyses. Average Causal Mediation Effect (ACME), Average Direct Effect (ADE), Total Effect estimates, and their 95%
confidence intervals (bars not including zero are statistically significant) for the effects of personality disorder (PD) diagnoses on suicide attempts (SAs). The four upper
panels display estimates with number of new SAs per month as an outcome (i.e., rate of attempts), whereas the four lower panels display estimates with new SA as an
outcome (i.e., attempter status). m¼ Proportion of PD effects on a new SA mediated by time spent in major depressive episodes (details in supplementary material).
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the effect, whereas obsessive-compulsive PD did not (8.2% [95%
CI¼38.9%, 79.7%]). Among all new SAs, not just those during
MDE, having an avoidant (n¼108) or dependent (n¼26) PD in-
creased the rate of attempts by 165% (95% CI¼104.2%, 244.7%).
Contrary to our expectations, borderline PD appeared less im-
portant in new SAs than cluster C (Table 3). The results did not
change in a sensitivity analysis examining VDS and JoBS patients
without the borderline PD suicidality item. Online Supplementary
analysis provides a breakdown of borderline PD symptoms in re-
lation to new SAs, showing that the number of symptoms lacked a
clear dose-response relationship with SA rate, whereas the avoi-
dant PD symptoms did have a dose-response effect on risk for SA.
Of borderline PD symptoms, identity disturbance was the only
predictor of new SAs, after adjusting for age, sex, having had a
previous suicide attempt, and number of previous attempts (in
detail in Supplementary material).
3.2. Mediating role of depressive episodes
We assessed whether the time spent in MDEs during the follow-up
mediated the effects of PDs on new SAs (Fig. 1). The effects of cluster B
and borderline PD on both SA rate and probability of a new SA were
clearly mediated by the time spent in MDEs. Cluster C appeared to
have mediated effects, with possible but non-significant direct effects
on SAs as well. Cluster A’s effects on SA rates were similarly mediated
by the time spent in MDEs, with some non-significant indications for
possible direct effects only when SAs were analyzed categorically.
3.3. Other risk factors and subgroups
We adjusted the PD-SA associations for several potential con-
founders and also evaluated them in relevant subgroups (Table 4).Table 4
Personality disorder-associated increases (%) in rate of new suicide attempts (SA)
under further adjustments and sensitivity analyses with multiple imputation
(n¼555).
Adjusted variable Any PD Cluster A Cluster B Cluster C Borderline
Original findings (for
reference)
101.5*** 68.3** 67.3*** 122.1*** 79.3***
Time spent in MDE 28.3 -0.3 2.1 52.3** 3.0
BDI 77.5*** 55.1** 42.9* 97.0*** 51.9**
BAI 74.0*** 49.0* 43.5* 96.0*** 53.8**
Psychotic symptoms 95.0*** 60.0** 66.3*** 113.0*** 75.3***
Hopelessness 75.6*** 39.9* 47.9** 101.3*** 55.3**
Social support 56.1** 23.0 32.6 97.2*** 40.6*
Married 97.5*** 67.7** 66.0*** 119.9*** 75.6***




84.3*** 91.2*** 101.2*** 104.2*** 112.5***
Bipolars only
(n¼176)




82.6 38.2 98.2 113.2 110.1
PD¼personality disorder; MDE¼major depressive episode; BDI¼Beck's depression
inventory; BAI¼Beck's Anxiety inventory; Adjusted variables refer to additional
adjusting of Poisson regression model with the indicated covariate, other covariates
being age, sex, having had a previous SA, number of previous SAs, and the diagnosis
indicated by the column. The estimate shown is for the increase in rate of new SAs
due to having the diagnosis at the baseline assessment. Original findings (first row)
without additional covariates are shown for reference, and the rows under the
heading “Subsample” refer to these analyses re-computed in the indicated
subsample.
* p-Value less than 0.05;
** p-Value less than 0.01;
*** p-Value less than 0.001.As expected from the mediation analysis, adjusting for the time
spent in MDEs attenuated all predictive effects for the rate of new
SAs, excluding the one for cluster C PD. In addition, the original
findings for clusters A and B were non-significant in BD patients
and were attenuated by adjusting for social support in all patients
(Table 4). Because the lack of studies on suicidality of primary care
patients has been emphasized (Hawton et al., 2013), we also
presented a subsample analysis of the small primary care sample
(n¼130). Despite low statistical power, the qualitative findings
were similar to those for the total sample.4. Discussion
Personality disorders have been known to increase mood dis-
order patients' risk of suicide attempts, but the reasons for this
have remained unclear. We investigated the relationship between
personality disorders (PDs) and suicide attempts (SAs) in three
prospectively studied mood disorder cohorts, finding the risk of
SAs to be generally two-fold among patients with a PD. A main
finding was that the influence of an individual’s PD on SA risk was
mostly indirect, mediated by increased time spent in high-risk
states, i.e. major depressive episodes (MDEs). However, PDs also
had some direct risk-modifying effects on SA rate during depres-
sive episodes; the best evidence for such influences emerged for
cluster C PDs.
This study has numerous methodological strengths. To our
knowledge, this is the first study evaluating whether the increased
suicidal behavior among PD patients could be explained (medi-
ated) by their greater time at risk (in depressive states) relative to
other patients. Information on SAs was gathered both retro-
spectively and prospectively during the follow-up, with consistent
findings of risk factors in both time-frames. The most important
strength was availability of prospectively collected life-charts with
information on illness course and timing of SAs, allowing testing of
mediator hypotheses. Patients were assessed prospectively with
semistructured interviews with excellent interrater reliability and
both objective and subjective structured and semistructured
measures. Information regarding all comorbid axis I and II dis-
orders at baseline was also available. Besides comorbid axis II
disorders, we investigated a broad range of risk and protective
factors from several domains, including axis I comorbid disorders
and symptoms, history of suicidal behavior, and psychosocial fac-
tors, on the risk of SAs. All cohorts employed similar methodology,
allowing valid comparisons and pooling of data.
Nevertheless, some limitations also exist. The lengths of follow-
ups differed, as the five-year follow-up data from the JoBS were
not yet available at the time of analysis. The data were therefore
modeled in Poisson regressions using the standard offset, or
length-of-exposure, term. Second, similarly to any study including
a retrospective evaluation, recall bias is possible, and depression
might affect recall of previous SAs. Third, although no specific
scale for the assessment of SAs was used (e.g the Suicide Intent
Scale, Beck et al., 1974), the evaluation of the rate of new SAs was
probably not over- or underestimated due to the thorough inter-
views, typically lasting 2–3 h and the life chart methodology used.
Fourth, it was only possible to investigate time spent in crudely
classified risk states instead of detailed temporal tracking of in-
dividual-specific risk states. Risk for attempts likely covaries sig-
nificantly with levels of depression, hopelessness, and possibly
anxiety, none of which were measured on a daily or moment-to-
moment basis. Thus, the observed gradient between symptom
states (Holma et al., 2010, 2014; Riihimaki et al., 2014a; Valtonen
et al., 2008) is likely an underestimate. Fifth, sample sizes re-
stricted the accuracy of estimates. Sixth, the study was naturalistic,
and treatments for mood disorders were not controlled, although
P. Jylhä et al. / Journal of Affective Disorders 190 (2016) 632–639638they may influence both the time ill and the risk for SAs. How
often comorbid personality disorders were clinically recognized
and whether treatments were focused on them remain unknown.
Seventh, the SCID-II interviews were based on DSM-IV in PC-VDS
and JoBS, but DSM-III-R in VDS. There are also minor differences in
PD diagnostic criteria between DSM-III-R and DSM-IV. Eigth, the
diagnostic criteria for borderline PD include suicidal behavior,
which to the degree that past “recurrent suicidal behavior, ges-
tures, or threats, or self-mutilating behavior” predicts future SAa
could cause a tautological increase in the predictive value of bor-
derline PD for future attempts. However, in a sensitivity analysis,
whether or not the suicide item was included in the diagnosis had
no influence on our findings. Ninth, we cannot exclude the pos-
sibility that some personality traits not fully captured by the DSM
PD constructs, e.g. impulsive or nonimpulsive aggressive traits
(Dalca et al., 2013; Keilp et al., 2006; Mann et al., 2009; McGirr
et al., 2008) might have important moderating effects on risk for
suicidal acts. Thus, a study of the influence of clinical PDs is not a
full account of the impact of all personality traits. Finally, it is
important to understand the nature of the cohorts investigated;
we investigated the influence of PDs on SAs among psychiatric
care patients with unipolar and bipolar major mood disorders and
among primary care patients with depressive disorders. General-
izability of findings to patients with PDs without mood disorders,
or to completed suicides among patients with mood disorders, not
to speak of other patients, requires further confirmation.
Diagnosis of any comorbid PD was associated with an ap-
proximately two-fold rate of both lifetime SAs and new (pro-
spectively observed) SAs among mood disorder patients, in
agreement with earlier studies (Bolton et al., 2010; Undurraga
et al., 2012). However, after adjustment for time spent in MDEs, all
of the associations, except those with cluster C PDs, were atte-
nuated and became non-significant. Thus, the influence of co-
morbid PD on the rate of new SAs is mostly mediated by the time
spent in high-risk state, i.e. in MDEs. This is consistent with our
previous study, where the influence of an individual’s tempera-
ment and character on suicide attempt risk was mediated by the
time spent in MDEs (Jylha et al., in Press). Thus, irrespective of
whether the variation in personality is conceptualized as a trait
dimension or a diagnostic category, its impact is mostly mediated
by an associated predisposition to spend extended periods in de-
pressive states, which then carry a high risk for suicidal acts.
A small and rarely discussed minority of individuals with mood
disorders suffer from cluster A PDs. We found that also these PDs
increased the rate of prospectively evaluated new SAs, even after
adjusting for age, gender, sampling cohort, and previous SAs. This
is in accord with a previous study (Bolton et al., 2010) in which
schizoid, paranoid, and schizotypal PDs were associated with fu-
ture SA. However, our finding was non-significant in bipolar pa-
tients, and was attenuated by adjusting for the generally weaker
social support among these patients, and only half of that total
effect was mediated by the time spent in MDE. Nevertheless, time
spent in MDEs during the follow-up mediated the effects of cluster
A PDs on the rate of new SAs. Overall, increased risk of SAs among
mood disorder patients with cluster A PDs is likely to be due to
multiple reasons, including increased time depressed, weaker so-
cial support, and direct effects of the PD when depressed. Whether
or not the cognitive distortions typical for these patients influence
the risk remains unknown.
Cluster B and borderline PDs increased the rate of lifetime and
new SAs. This was expected and fully in line with earlier studies
(Bolton et al., 2010; Soloff and Chiappetta, 2012; Soloff and Fabio,
2008; Yen et al., 2003). Of separate DSM-IV borderline PD criteria
only identity disturbance predicted new SAs after adjusting forage, sex, having had a previous suicide attempt, and number of
previous attempts. This finding is in contrast to an earlier study
(Yen et al., 2004), in which affective instability most strongly as-
sociated with suicidal behavior. In our analysis, the effect of Cluster
B and borderline PD on both the rate and probability of new SAs
was clearly found to be mediated by the time spent in MDEs.
While this is concordant with findings of the US NESARC study
(Skodol et al., 2011), we nevertheless also expected a major risk-
modifying effect when depressed. Three factors may have influ-
enced our findings. First, while we deliberately included mood
disorder patients with all types of comorbid disorders in the co-
horts, patients with substance-induced mood episodes were not
included. Thus, some of the borderline PD patients most at risk for
suicidal behavior were possibly excluded, and those included were
likely less substance-abusing than borderline patients at large.
Second, the mean age of about 40 years in the mood disorder
cohorts differs from most cohort studies of borderline PD, which
mostly involve young adults. Therefore, the clinical profile of our
patients was likely also different, reflecting later phases in the
course of PDs. Third, in the absence of specialized services for
patients with borderline PD at the time of data collection, highly
impulsive patients may have visited psychiatric settings only
briefly at times of crisis and might thus have been less likely to be
included in the two psychiatric cohorts. Therefore, while our
findings provide evidence for the risk-increasing role of borderline
PD because of more time spent depressed, they do not negate the
findings of studies determining other aspects of borderline psy-
chopathology to be important.
Cluster C PDs are generally not perceived to markedly con-
tribute to the risk of suicidal acts. However, we found them to play
an important role among mood disorder patients due to their
strong influence on chronicity and recurrences of unipolar and
bipolar mood disorders (Holma et al., 2008; Pallaskorpi et al.,
2015), and the associated increase in the rate of lifetime and
prospectively evaluated new SAs. This impact of comorbid cluster
C PDs (that is not found with comorbid cluster B PDs) on the in-
creased risk of SAs might be due to other common underlying risk
factors affecting on chronicity and recurrences of mood disorders
e.g. personality traits (Rosenström et al., 2014) or low level of so-
cial support (Leskelä et al., 2004). In line with our finding, new SAs
were also found to be associated with cluster C PDs in a previous
study (Oleski et al., 2012). Moreover, even during the high-risk
period of MDE, cluster C PDs nearly doubled the SA rate. It is
possible that the influence on risk of suicidal acts varies depending
on the specific PD. In post-hoc analyses, we found that during the
total follow-up cluster C, avoidant, and dependent PDs, but not
obsessive-compulsive PD, increased the rate of new SAs by 165%.
Moreover, the number of symptoms for avoidant PD had a rough
dose-response relationship with the rate of new SAs. About half of
the effect of cluster C PDs on the rate of new SAs, and about 2/3 of
the effect on the probability of making at least one SA, was
mediated by the time spent in MDEs. Thus, cluster C PDs seem to
have an effect on SAs both by increasing time at risk and by in-
creasing risk when depressed.
In conclusion, among mood disorder patients, comorbid PDs
increase the risk of SAs by approximately two-fold. The excess risk
is mostly due to the finding that patients with comorbid PDs
spend more time in depressive episodes than those without co-
morbid PDs. Consequently, the risk was highest for PDs that most
strongly predispose to more time depressed. This putative causal
pathway has important clinical implications because MDEs are
treatable. However, direct risk-modifying effects of PDs are also
likely to exist.
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